1. Advances in Cystic Fibrosis Perspectives From Orlando, 2016

3. Update on Inhaled Antibiotics

4. Inhaled Levofloxacin vs Inhaled Tobramycin

5. Findings

6. Does Inhaled Aztreonam Affect the CF Lung Microbiome?

7. Observations

8. CFTR Modulators in Young Children

9. Long-Term Safety and Efficacy of Ivacaftor in Children Aged 2 to 5 Years KLIMB

10. Ivacaftor in Children Aged 2 to 5 Years -- Results

11. Commentary

12. Lumacaftor/Ivacaftor in Children Aged 6 to 11 Years

13. AEs Reported

14. Lumacaftor/Ivacaftor in Children Aged 6 to 11 Years -- Observations

15. Patient Education in Preventing Infection

16. Reducing Transmission of Pseudomonas aeruginosa?

17. Methods

18. Face Masks -- Findings

19. Family Attitudes Toward Infection Control

20. Commentary

21. Abbreviations

22. Abbreviations (cont)